signal

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 59/100

   Safety of lecanemab in real-world patients with Alzheimer's disease: a prospective, observational case series supported by FAERS signal analysis

   ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Frontiers in neuroinformatics · 2026-10-02 · Treatments

   Although clinical trials have demonstrated its favorable safety profile, real-world studies are crucial for identifying rare adverse events (AEs) and evaluating post-marketing safety.

   • Treatments
   • Side Effects
2. 59/100

   Disproportionality analysis of adverse event signals associated with seven Alzheimer's drugs: insights from the FAERS database

   ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Frontiers in pharmacology · 2026-09-24 · Treatments

   This study utilized FAERS data to compare adverse event reporting signals for seven anti-AD drugs.

   • Treatments
   • Side Effects
3. 57/100

   Post-marketing safety signals and report-level ARIA-E stratification for lecanemab and donanemab: an integrated FAERS and WHO-VigiAccess pharmacovigilance study

   ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Therapeutic advances in drug safety · 2026-08-18 · Treatments

   FAERS included 2961 lecanemab and 1542 donanemab primary suspect reports; WHO-VigiAccess included 2525 lecanemab- and 1450 donanemab-related reports.

   • Side Effects
   • Treatments
4. 41/100

   Electrochemical Biosensors Combined with Nanomaterial Signal Amplification for the Detection of Alzheimer's Disease Biomarkers in Blood

   ✓ Peer-reviewed alzhub usefulness score 41 out of 100. ACS sensors · 2025-09-08 · Biomarkers

   Alzheimer's disease (AD) is a progressive neurodegenerative disorder primarily characterized by cognitive decline and behavioral impairments, typically manifesting in the elderly and presenile population.

   • Biomarkers
   • Brain Biology
5. 48/100

   Subcortical signal alteration of corticospinal tracts. A radiologic manifestation of ARIA: A case report

   ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Radiology case reports · 2022-11-06 · Treatments

   The brain MRI demonstrated new FLAIR hyper signal intensity in subcortical regions of precentral gyri (motor cortex) symmetrically as well as trace subarachnoid hemorrhage at the vertex compatible with ARIA-E and ARIA-H. After tolerating 6 doses of aducanumab a safety MRI revealed new bilateral symmetric FLAIR hyper signal intensity in the subcortical motor cortex.

   • Side Effects
6. 48/100

   Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission

   ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Brain : a journal of neurology · 2015-06-29 · Genetics

   Defects of mitochondrial dynamics are emerging causes of neurological disease.

   • Brain Biology
7. 36/100

   Functional screening of Alzheimer pathology genome-wide association signals in Drosophila

   ✓ Peer-reviewed alzhub usefulness score 36 out of 100. American journal of human genetics · 2011-02-03 · Genetics

   We have leveraged a Drosophila model relevant to Alzheimer disease (AD) for functional screening of findings from a genome-wide scan for loci associated with a quantitative measure of AD pathology in humans.

   • Genetics
   • Diagnosis

All topic tags with their study counts